Posted by Michael Wonder on 26 Aug 2020
Drug industry lobbyists circulate two drug pricing proposals in hopes of warding off a Trump executive order
25 August 2020 - The pharmaceutical industry is weighing two drug pricing policies that it could offer as a trade to President Trump, in exchange for his dropping a different proposal that drug makers detest, according to three drug industry lobbyists.
Trump told drug makers last month they had until Monday to come up with a way to significantly lower drug prices, or he would implement, via executive order, a “Most Favored Nations” policy, which would require drug makers sell injectable drugs for the lowest price they offer similar countries.
